ABBOT Stewart,EDINGER James,FRANCKI Aleksander,HARIRI Robert J.,JANKOVIC Vladimir,KAPLUNOVSKY Aleksandr,LABAZZO Kristen,LAW Eric,PADLIYA Neerav,PAREDES Jennifer,WANG Jia-Lun,KAPLUNOVSKY Al
申请号：
SI201130988
公开号：
SI2556145T1
申请日:
2011.04.06
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
The invention provides a population of placental-derived adherent cells that are CD10+, CD34-, CD105+, and CD200+ for use in a method for treatment of an individual having a disease or injury of the heart or circulatory system. Said placental-derived adherent cells may additionally be one or more of CD45-, CD90+, or OCT-4+.
